Prostate ewing sarcoma/PNET: a case of long survival in a highly aggressive malignancy

Carolina Borges da Ponte; Tito Palmela Leitão; Miguel Miranda; Joana Polido; Cecília Alvim; Isabel Fernandes; Teresa Braga; Bárbara Pena; José Mendes de Almeida; Luís Costa; José Palma dos Reis

doi:10.1016/j.urology.2021.05.006

Prostate ewing sarcoma/PNET: a case of long survival in a highly aggressive malignancy

Carolina Borges da Ponte^*
, Tito Palmela Leitão
, Miguel Miranda
, Joana Polido
, Cecília Alvim
, Isabel Fernandes
, Teresa Braga
, Bárbara Pena
, José Mendes de Almeida
, Luís Costa
, José Palma dos Reis

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

6 Citations (Scopus)

Abstract

Prostate Ewing sarcoma/peripheral primitive neuroectodermal tumor (ES/PNET) is extremely rare. Currently, a multimodal approach is recommended, although there is no standard treatment. Nevertheless, this tumor has a very poor prognosis, with the longest reported survival of 24 months. We present a case of locally advanced prostate ES/PNET in a 29-year-old male who was treated with a multimodal approach. The patient is alive and disease free, with a seven year follow-up, with very good quality of life. This exceptionally long survival may be the result of the very aggressive multimodal treatment chosen and described herein.

Original language	English
Pages (from-to)	e11-e12
Number of pages	2
Journal	Urology
Volume	154
DOIs	https://doi.org/10.1016/j.urology.2021.05.006
Publication status	Published - Aug 2021
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.urology.2021.05.006Licence: Other

Cite this

@article{d257729d44b647cca6039739cfd74a54,

title = "Prostate ewing sarcoma/PNET: a case of long survival in a highly aggressive malignancy",

abstract = "Prostate Ewing sarcoma/peripheral primitive neuroectodermal tumor (ES/PNET) is extremely rare. Currently, a multimodal approach is recommended, although there is no standard treatment. Nevertheless, this tumor has a very poor prognosis, with the longest reported survival of 24 months. We present a case of locally advanced prostate ES/PNET in a 29-year-old male who was treated with a multimodal approach. The patient is alive and disease free, with a seven year follow-up, with very good quality of life. This exceptionally long survival may be the result of the very aggressive multimodal treatment chosen and described herein.",

author = "\{Borges da Ponte\}, Carolina and Leit{\~a}o, \{Tito Palmela\} and Miguel Miranda and Joana Polido and Cec{\'i}lia Alvim and Isabel Fernandes and Teresa Braga and B{\'a}rbara Pena and \{de Almeida\}, \{Jos{\'e} Mendes\} and Lu{\'i}s Costa and \{dos Reis\}, \{Jos{\'e} Palma\}",

note = "Publisher Copyright: {\textcopyright} 2021 Elsevier Inc.",

year = "2021",

month = aug,

doi = "10.1016/j.urology.2021.05.006",

language = "English",

volume = "154",

pages = "e11--e12",

journal = "Urology",

issn = "0090-4295",

publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Prostate ewing sarcoma/PNET

T2 - a case of long survival in a highly aggressive malignancy

AU - Borges da Ponte, Carolina

AU - Leitão, Tito Palmela

AU - Miranda, Miguel

AU - Polido, Joana

AU - Alvim, Cecília

AU - Fernandes, Isabel

AU - Braga, Teresa

AU - Pena, Bárbara

AU - de Almeida, José Mendes

AU - Costa, Luís

AU - dos Reis, José Palma

PY - 2021/8

Y1 - 2021/8

N2 - Prostate Ewing sarcoma/peripheral primitive neuroectodermal tumor (ES/PNET) is extremely rare. Currently, a multimodal approach is recommended, although there is no standard treatment. Nevertheless, this tumor has a very poor prognosis, with the longest reported survival of 24 months. We present a case of locally advanced prostate ES/PNET in a 29-year-old male who was treated with a multimodal approach. The patient is alive and disease free, with a seven year follow-up, with very good quality of life. This exceptionally long survival may be the result of the very aggressive multimodal treatment chosen and described herein.

AB - Prostate Ewing sarcoma/peripheral primitive neuroectodermal tumor (ES/PNET) is extremely rare. Currently, a multimodal approach is recommended, although there is no standard treatment. Nevertheless, this tumor has a very poor prognosis, with the longest reported survival of 24 months. We present a case of locally advanced prostate ES/PNET in a 29-year-old male who was treated with a multimodal approach. The patient is alive and disease free, with a seven year follow-up, with very good quality of life. This exceptionally long survival may be the result of the very aggressive multimodal treatment chosen and described herein.

UR - https://www.scopus.com/pages/publications/85108501346

U2 - 10.1016/j.urology.2021.05.006

DO - 10.1016/j.urology.2021.05.006

M3 - Article

C2 - 34010676

AN - SCOPUS:85108501346

SN - 0090-4295

VL - 154

SP - e11-e12

JO - Urology

JF - Urology

ER -

Prostate ewing sarcoma/PNET: a case of long survival in a highly aggressive malignancy

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this